Clinical Trials Logo

Stage III Osteosarcoma AJCC v7 clinical trials

View clinical trials related to Stage III Osteosarcoma AJCC v7.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03213678 Active, not recruiting - Malignant Glioma Clinical Trials

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Start date: November 28, 2017
Phase: Phase 2
Study type: Interventional

This phase II Pediatric MATCH trial studies how well samotolisib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with TSC or PI3K/MTOR mutations that have spread to other places in the body (metastatic) and have come back (recurrent) or do not respond to treatment (refractory). Samotolisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02243605 Active, not recruiting - Clinical trials for Recurrent Osteosarcoma

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Start date: December 19, 2014
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well cabozantinib s-malate works in treating patients with osteosarcoma or Ewing sarcoma that has grown or returned (come back) after a period of improvement. Cabozantinib s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and may also prevent the growth of new blood vessels that tumors need to grow.